Page last updated: 2024-11-02

oxiracetam and Brain Concussion

oxiracetam has been researched along with Brain Concussion in 2 studies

oxiracetam: structure in first source

Brain Concussion: A nonspecific term used to describe transient alterations or loss of consciousness following closed head injuries. The duration of UNCONSCIOUSNESS generally lasts a few seconds, but may persist for several hours. Concussions may be classified as mild, intermediate, and severe. Prolonged periods of unconsciousness (often defined as greater than 6 hours in duration) may be referred to as post-traumatic coma (COMA, POST-HEAD INJURY). (From Rowland, Merritt's Textbook of Neurology, 9th ed, p418)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (50.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (50.00)2.80

Authors

AuthorsStudies
Niu, F1
Sharma, A1
Wang, Z1
Feng, L1
Muresanu, DF1
Sahib, S1
Tian, ZR1
Lafuente, JV1
Buzoianu, AD1
Castellani, RJ1
Nozari, A1
Menon, PK1
Patnaik, R1
Wiklund, L1
Sharma, HS1
Russello, D1
Randazzo, G1
Favetta, A1
Cristaldi, C1
Petino, AG1
Carnazzo, SA1
Latteri, F1

Trials

1 trial available for oxiracetam and Brain Concussion

ArticleYear
[Oxiracetam treatment of exogenous post-concussion syndrome. Statistical evaluation of results].
    Minerva chirurgica, 1990, Oct-31, Volume: 45, Issue:20

    Topics: Adolescent; Adult; Aged; Aged, 80 and over; Brain Concussion; Female; Humans; Male; Middle Aged; Pyr

1990

Other Studies

1 other study available for oxiracetam and Brain Concussion

ArticleYear
Nanodelivery of oxiracetam enhances memory, functional recovery and induces neuroprotection following concussive head injury.
    Progress in brain research, 2021, Volume: 265

    Topics: Brain Concussion; Humans; Nanowires; Neuroprotection; Neuroprotective Agents; Pyrrolidines; Quality

2021